Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

BISMUTH SUBSALICYLATE TABLETS

Awarded
SPE2DP26F7915Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the procurement of Bismuth Subsalicylate Tablets, with a total contract value of $1.60. The award was issued on July 21, 2026, under solicitation SPE2DP26F7915, and the item is identified by NSN 6505014437607 and PR number 7017583149. This acquisition falls under FAR Part 12 as a commercial item purchase, governed by standard commercial terms including FAR 52.212-4 and FAR 52.212-5, with the offeror required to affirm representations through FAR 52.212-3. The contract includes mandatory compliance with FAR 52.222-50 addressing combating trafficking in persons and is designated as a rated order under the Defense Priorities and Allocations System (DPAS), obligating the contractor to prioritize fulfillment. Delivery is FOB Destination to Morrisville, North Carolina, with the contractor bearing all transportation costs and risks until receipt by the government. Shipment must be sent via traceable means, explicitly prohibiting parcel post, and must include proper marking with the Transportation Control Number, CAGE code, and National Drug Code. The contract administration is managed by DLA Troop Support, Medical Supply Chain FSB in Philadelphia, Pennsylvania, with Catherine Gilbert as the local administrative contact. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio, and invoices must be submitted to that address. The award is structured as a single line item with no option quantities, though the underlying IDIQ contract has a ceiling of nearly $20 million, indicating the potential for future orders. Inspection and acceptance occur at the destination, with government authority retaining responsibility for both functions. The contractor’s CAGE code is 1UNB0, and the NAICS code is 325412, with the solicitation set aside for small business, HUBZone, service-disabled veteran-owned small business, and Women-Owned Small Business categories, though the offeror’s self-certified size status is not confirmed. Packaging, preservation, and labeling requirements reference DoD logistics standards through the use of TCN, CAGE, and NDC but

General Info

DMS PHARMACEUTICAL GROUP to supply bismuth subsalicylate tablets for $1.60 under DLA contract.

Contract Value

$1.6

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

Contract SPE2DP26F7915 for Bismuth Subsalicylate Tablets

PDF, High priority: read this firstcontract-document
High

Contract SPE2DX-25-D-9900 for Commercial Items Base Admin

PDF, High priority: read this firstcontract-document
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7915 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $1.60 Award Date: 07-21-2026 Delivery order under: SPE2DX25D9900 Line items: - BISMUTH SUBSALICYLATE TABLETS (NSN/Part 6505014437607, PR 7017583149)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
LORATADINE TABLETS
Solicitation # SPE2DP-27-T-0208
Solicitation SPE2DP-27-T-0208, issued by DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Loratadine 10 mg tablets (NSN 6505-01-524-9179). The requirement is for two bottles, with each bottle containing 500 tablets. The items are FDA-regulated and must be stored between 20° to 25° C and protected from excessive moisture. The product is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with terms set as FOB Destination and performance located at Camp Pendleton, California. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various federal regulations, including the Buy American Act, DFARS requirements for safeguarding covered defense information, and prohibitions on certain telecommunications equipment. Quotations are due by November 4, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS